The production, sales and export volume of leading products are in the forefront of the same industry in the country
Shandong Aocter Biotechnology Co., Ltd is a national key manufacturer and exporter of feed additives, biological functional foods, biological enzymes, biological pharmaceutical raw materials and other products, and its products are exported to 80 countries and regions. The production, sales and export volume of leading products are in the forefront of the same industry in the country. The group and its subordinate enterprises are national high-tech enterprises, national intellectual property advantage enterprises, Shandong gazelle enterprises, Shandong technology innovation demonstration enterprises, and Shandong province specialized, special, new, small and medium-sized enterprises. Enterprise, provincial manufacturing single champion enterprise, Shandong Province small and medium-sized invisible champion enterprise, Shandong Province post-doctoral innovation practice base, Shandong Province key industrial enterprise, Shandong Province engineering laboratory recognized unit, provincial key enterprise technology center recognized enterprise.
Aocter Group is a representative of companies participating in the revision of the EU feed additive (choline chloride) standard. Participated in the formulation of the national standard for feed additive "Allicin" and the formulation of two national food safety standards, including "choline bitartrate" and "choline chloride for food nutrition fortifier". Cooperate with Zhejiang University of Technology, Nankai University, Shandong University, East China University of Science and Technology and other institutions of higher learning. In 2020, we will cooperate with Shandong University to undertake the "Taishan Industry Leading Talents" project (strategic emerging category) to develop and produce implantable medical device-related products. In the same year, R&D and production of pharmaceutical raw materials have achieved remarkable benefits from the advancement of technology and the promotion and expansion of domestic and foreign markets. In 2022, we will invest in the construction of the third-generation functional sugar project, which will be included in the "Shandong Province New and Old Kinetic Energy Conversion Major Project Library Preferred Project". It is a new functional ingredient that is currently developed internationally and is beneficial to human health.
Following the national industrial development strategy, Aocter will further increase investment in scientific and technological innovation in the future development, and extend in the direction of higher precision and high added value.
©2022 Aocter Group
Webpage Copyright © 2022 Aocter Group